Business Context and Reporting Period
Company: The Estée Lauder Companies Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: December 31, 2008 (Fiscal Second Quarter 2009)
Business Overview: The Company manufactures, markets, and sells beauty products (skin care, makeup, fragrance, hair care) in over 140 countries. The reporting period was significantly impacted by the global financial crisis, resulting in reduced consumer demand, retailer destocking, and a strengthening U.S. dollar.
Key Financial Metrics
| Metric (in millions) | 3 Months Ended Dec 31, 2008 | 6 Months Ended Dec 31, 2008 | 3 Months Ended Dec 31, 2007 | 6 Months Ended Dec 31, 2007 |
|---|---|---|---|---|
| Net Sales | $2,041.0 | $3,944.5 | $2,308.8 | $4,018.9 |
| Gross Profit | $1,533.0 | $2,936.4 | $1,730.3 | $2,984.6 |
| Operating Income | $270.3 | $362.8 | $370.5 | $448.4 |
| Net Earnings | $158.0 | $209.1 | $224.4 | $263.5 |
| Diluted EPS | $0.80 | $1.06 | $1.14 | $1.34 |
| Cash from Operations (6mo) | $216.7 (2008) vs $361.9 (2007) | |||
| Cash & Equivalents (Dec 31, 2008) | $728.9 | |||
| Total Debt (Dec 31, 2008) | $1,655.1 ($248.7 Short-term / $1,406.4 Long-term) |
Margins (6 Months Ended Dec 31, 2008):
- Gross Margin: 74.4%
- Operating Margin: 9.2%
- Net Margin: 5.3%
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 12% ($267.8M) in the quarter and 2% ($74.4M) for the six-month period compared to the prior year. Declines were driven by the Americas (-12% Q, -4% 6mo) and Europe/Middle East/Africa (-18% Q, -5% 6mo), partially offset by growth in Asia/Pacific (+8% Q, +15% 6mo).
- Profitability Compression: Operating income fell 27% in the quarter and 19% for the six months. Operating margins contracted from 16.0% to 13.2% (quarter) and 11.2% to 9.2% (six months) due to sales declines outpacing cost containment efforts.
- Product Category Performance: Fragrance sales were the hardest hit, down 20% in the quarter, driven by declines in designer fragrances (e.g., DKNY, Sean John). Skin Care sales were relatively resilient, up 3% for the six months, driven by new product launches.
- Currency Impact: A strengthening U.S. dollar negatively impacted reported sales and earnings. Excluding currency effects, net sales decreased 6% in the quarter but increased 1% for the six months.
- Debt Structure: In November 2008, the Company issued $300 million of 7.75% Senior Notes due 2013 to repay commercial paper and maintain liquidity. Total debt as a percent of total capitalization increased to 50% from 42%.
Guidance, Outlook, and Risks
- Restructuring Initiative: Subsequent to the period end, the Company announced a multi-faceted cost savings and reorganization program. Management anticipates one-time restructuring and special charges between $350 million and $450 million to be rolled out over the next few fiscal years.
- Outlook: Management expects the global financial crisis, retailer destocking, and currency headwinds to continue negatively affecting net sales and operating results for the remainder of the fiscal year. Uncertainty regarding consumer spending and retailer financial strength remains high.
- Strategic Focus: The Company plans to continue investing in fast-growing markets and channels, with Skin Care identified as a priority for strategic spending.
- Risks:
- Goodwill Impairment: While management concluded reporting units still had fair value in excess of carrying value despite stock price declines, they noted the possibility of future impairment charges if economic volatility persists.
- Legal Contingencies: Ongoing litigation regarding the Blydenburgh landfill; management believes the outcome will not be material but settlement discussions are ongoing.
- Market Risk: Exposure to foreign currency fluctuations and interest rate changes, managed through hedging activities.
Investor Verification Checklist
- Restructuring Costs: Verify the specific timing and cash impact of the announced $350M-$450M restructuring charges.
- Inventory Levels: Monitor inventory turnover and obsolescence charges, which increased by approximately 40-50 basis points in cost of sales percentages.
- Debt Servicing: Review the impact of the new 7.75% Senior Notes on future interest expense and cash flow.
- Regional Recovery: Assess the sustainability of growth in Asia/Pacific versus the depth of the downturn in the Americas and Europe.
- Goodwill Valuation: Watch for interim impairment testing triggers given the volatility in the Company's stock price and market capitalization.